These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9850978)

  • 1. CSF N-CAM in neuroleptic-naïve first-episode patients with schizophrenia.
    Vawter MP; Hemperly JJ; Freed WJ; Garver DL
    Schizophr Res; 1998 Nov; 34(3):123-31. PubMed ID: 9850978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated concentration of N-CAM VASE isoforms in schizophrenia.
    Vawter MP; Frye MA; Hemperly JJ; VanderPutten DM; Usen N; Doherty P; Saffell JL; Issa F; Post RM; Wyatt RJ; Freed WJ
    J Psychiatr Res; 2000; 34(1):25-34. PubMed ID: 10696830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disturbances in cell recognition molecules (N-CAM and L1 antigen) in the CSF of patients with schizophrenia.
    Poltorak M; Khoja I; Hemperly JJ; Williams JR; el-Mallakh R; Freed WJ
    Exp Neurol; 1995 Feb; 131(2):266-72. PubMed ID: 7895825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased neural cell adhesion molecule in the CSF of patients with mood disorder.
    Poltorak M; Frye MA; Wright R; Hemperly JJ; George MS; Pazzaglia PJ; Jerrels SA; Post RM; Freed WJ
    J Neurochem; 1996 Apr; 66(4):1532-8. PubMed ID: 8627309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further studies of elevated cerebrospinal fluid neuronal cell adhesion molecule in schizophrenia.
    van Kammen DP; Poltorak M; Kelley ME; Yao JK; Gurklis JA; Peters JL; Hemperly JJ; Wright RD; Freed WJ
    Biol Psychiatry; 1998 May; 43(9):680-6. PubMed ID: 9583002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration in serum neural cell adhesion molecule in patients of schizophrenia.
    Tanaka Y; Yoshida S; Shimada Y; Ueda H; Asai K
    Hum Psychopharmacol; 2007 Mar; 22(2):97-102. PubMed ID: 17266166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid oxytocin concentration in schizophrenic patients does not differ from control subjects and is not changed by neuroleptic medication.
    Glovinsky D; Kalogeras KT; Kirch DG; Suddath R; Wyatt RJ
    Schizophr Res; 1994 Feb; 11(3):273-6. PubMed ID: 7910756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of hippocampal secreted N-CAM in bipolar disorder and synaptophysin in schizophrenia.
    Vawter MP; Howard AL; Hyde TM; Kleinman JE; Freed WJ
    Mol Psychiatry; 1999 Sep; 4(5):467-75. PubMed ID: 10523820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CSF concentrations of neurotensin in schizophrenia: an investigation of clinical and biochemical correlates.
    Breslin NA; Suddath RL; Bissette G; Nemeroff CB; Lowrimore P; Weinberger DR
    Schizophr Res; 1994 Apr; 12(1):35-41. PubMed ID: 7517175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of human cleaved N-CAM and association with schizophrenia.
    Vawter MP; Usen N; Thatcher L; Ladenheim B; Zhang P; VanderPutten DM; Conant K; Herman MM; van Kammen DP; Sedvall G; Garver DL; Freed WJ
    Exp Neurol; 2001 Nov; 172(1):29-46. PubMed ID: 11681838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic GMP in the CSF of patients with schizophrenia before and after neuroleptic treatment.
    Ebstein RP; Biederman J; Rimon R; Zohar J; Belmaker RH
    Psychopharmacology (Berl); 1976 Dec; 51(1):71-4. PubMed ID: 13448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A morphometric MRI study of the hippocampus in first-episode, neuroleptic-naïve schizophrenia.
    Laakso MP; Tiihonen J; Syvälahti E; Vilkman H; Laakso A; Alakare B; Räkköläinen V; Salokangas RK; Koivisto E; Hietala J
    Schizophr Res; 2001 May; 50(1-2):3-7. PubMed ID: 11378309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Striatal dopamine D2 receptor density in neuroleptic-naive and in neuroleptic-free schizophrenic patients: an 123I-IBZM-SPECT study.
    Lomeña F; Catafau AM; Parellada E; Bernardo M; Font M; Gutiérrez F; Pavía J
    Psychopharmacology (Berl); 2004 Mar; 172(2):165-9. PubMed ID: 14624330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VASE-containing N-CAM isoforms are increased in the hippocampus in bipolar disorder but not schizophrenia.
    Vawter MP; Hemperly JJ; Hyde TM; Bachus SE; VanderPutten DM; Howard AL; Cannon-Spoor HE; McCoy MT; Webster MJ; Kleinman JE; Freed WJ
    Exp Neurol; 1998 Nov; 154(1):1-11. PubMed ID: 9875262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher cerebrospinal fluid angiotensin-converting enzyme levels in neuroleptic-treated than in drug-free patients with schizophrenia.
    Wahlbeck K; Ahokas A; Miettinen K; Nikkilä H; Rimón R
    Schizophr Bull; 1998; 24(3):391-7. PubMed ID: 9718631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid neural cell adhesion molecule levels and their correlation with clinical variables in patients with schizophrenia, bipolar disorder, and major depressive disorder.
    Hidese S; Hattori K; Sasayama D; Miyakawa T; Matsumura R; Yokota Y; Ishida I; Matsuo J; Noda T; Yoshida S; Teraishi T; Hori H; Ota M; Kunugi H
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jun; 76():12-18. PubMed ID: 28238731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of olanzapine treatment on brain regional glucose metabolism in neuroleptic-naive first-episode schizophrenic patients.
    Yoshimuta H; Nakamura M; Kanda E; Fujita S; Takeuchi K; Fujimoto T; Nakabeppu Y; Akasaki Y; Sano A
    Hum Psychopharmacol; 2016 Nov; 31(6):419-426. PubMed ID: 27859668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum amino acids, central monoamines, and hormones in drug-naive, drug-free, and neuroleptic-treated schizophrenic patients and healthy subjects.
    Rao ML; Gross G; Strebel B; Bräunig P; Huber G; Klosterkötter J
    Psychiatry Res; 1990 Dec; 34(3):243-57. PubMed ID: 1981623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma homovanillic acid levels and therapeutic outcome in schizophrenics: comparisons of neuroleptic-naive first-episode patients and patients with disease exacerbation due to neuroleptic discontinuance.
    Akiyama K; Tsuchida K; Kanzaki A; Ujike H; Hamamura T; Kondo K; Mutoh S; Miyanagi K; Kuroda S; Otsuki S
    Biol Psychiatry; 1995 Nov; 38(10):639-48. PubMed ID: 8555375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroleptic effects on P50 sensory gating in patients with first-episode never-medicated schizophrenia.
    Hong X; Chan RC; Zhuang X; Jiang T; Wan X; Wang J; Xiao B; Zhou H; Jiang L; Weng B
    Schizophr Res; 2009 Mar; 108(1-3):151-7. PubMed ID: 19106034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.